PHOENIX, Aug. 27, 2018 (GLOBE NEWSWIRE) — Premier Biomedical, Inc. (OTCQB:BIEI) (the “Company”), announced President and CEO William A.Â Hartman’s interview on Uptick Newswire’s “Stock Day” Podcast.
Everett Jolly began the interview by welcoming back Premier Biomedical, Inc. President and CEO William A.Â Hartman for a Company update since July 2018. Jolly stated that he still thinks this Company is undervalued even after their 250:1-split. Jolly asked Hartman to give his listeners information about their latest developments.
Hartman got right to the point. Premier Biomedical has recently formed an agreement with an ex-Army purchasing group called “4Â Your Pain.” This group has taken on the task of introducing Premier Biomedical’s CBD topical pain relief products to the military and to the government as an alternative to dangerous and addictive opioid pain medications. The Company’s goal is to be the primary source for all pain medications for the military and governmental agencies.
Hartman added, “What is driving the market explosion of our superior topical pain relief products is the fact that almost 200 people per day are dying from drug overdoses and a recent study concluded that almost 70% of those people started on opioid pain medications. This is a real opioid crisis in this country.”
Premier Biomedical’s primary focus is the manufacture and distribution of all-natural, 50-state legal, pesticide- and solvent-free hemp oil-based pain management products, including 96-hour pain relief patches, roll-on applicators, ointments and pump sprays sold on the Company’s website at www.painreliefmeds.com and at select pharmacies and doctors’ offices.
Jolly wanted to know what makes the Company’s products so special. Hartman indicated that it was a combination of things, including a unique formulation and products containing much more CBD than the competition. Their new line of Extra Strength Pain-Ex IIâ„¢ products have even more CBD than competition at-market prices.Â That means real pain relief, which is what people suffering from pain are seeking.
Premier Biomedical also has recently re-organized their industry-leading technologies in their separate Biologics Division. The Company recently placed these on-the-shelf technologies into separate centers of expertise, providing specific technology investors assurance of focused use of funds without diluting the Company’s stock. The Company announced this as a win for technology investors and a win for stockholders.
Jolly asked what listeners should take away from this interview. Hartman said the biggest thing we have coming is a potential near-term joint venture, which will help expand the Company dramatically. He can’t say any more because it’s not finalized, but this is just a teaser for your podcast listeners.
Hartman concluded, “We’re a Company about change. We’re a Company about responding to the market and responding to our investors. We have experienced many challenges, but we have erupted from them even stronger than ever. I see a brilliant future for this Company!” Hartman stated that he looks forward to returning to the podcast in the near future with another exciting update.
For more information about the Company’s financial details, listen to the full interview at the link below.
About Premier Biomedical, Inc. ( BIEI ):
Premier Biomedical, Inc., is in part a research-based company that primarily intends to discover and develop medical products. Our current focus is on the distribution of our pain management products. Our current pain management products are made from hemp oil extracts and include roll-on applicators, pain relief patches, creams and pump stray applicators. We also conduct research and development of proprietary drugs and techniques to target PTSD, cancer, anti-aging, multiple sclerosis and other diseases.
Premier Biomedical, Inc.
P.O. Box 25
Jackson Center, PA 16133
Safe Harbor Act and Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
About Uptick Newswire and the “Stock Day” Podcast
Founded in 2013, Uptick Newswire is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Uptick provides companies with customized solutions to their news distribution in both national and international media outlets. Uptick is the sole producer of its “Stock Day” Podcast, which is the number one radio show of its kind in America. The Uptick Network “Stock Day” Podcast is an extension of Uptick Newswire, which recently launched its Video Interview Studio located in Phoenix, Arizona.
Investors Hangout is a proud sponsor of “Stock Day,” and Uptick Newswire encourages listeners to visit the company’s message board at https://investorshangout.com/
Source: Premier Biomedical, Inc.